Lumida
/TCRX
⌘K
TScan Therapeutics Inc

TScan Therapeutics Inc

TCRX
$0.32USD+0.79%+0.00 today

MARKET CAP

21.7M

P/E (TTM)

FWD P/E

DAY RANGE

$0 – $0

52W RANGE

$0
$3
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$10.1M$13.5M$21.0M$2.8M$10.3M
YoY %+33.5%+55.5%-86.6%+266.7%
P / Sales5.2x3.0x17.8x120.9x12.6x
EV / Sales-8.0x1.5x17.2x103.7x8.0x
Gross Profit, Adj.$10.1M$13.5M$21.0M$2.8M$10.3M
YoY %+33.5%+55.5%-86.6%+266.7%
Margin %100.0%100.0%100.0%100.0%100.0%
EV / Gross Profit-8.0x1.5x17.2x103.7x8.0x
EBITDA, Adj.$-45.3M$-61.5M$-88.1M$-130.7M$-132.9M
YoY %-35.7%-43.2%-48.4%-1.7%
Margin %-446.8%-454.4%-418.5%-4641.8%-1287.6%
EV / EBITDA1.8x-0.3x-4.1x-2.2x-0.6x
EBIT$-48.6M$-66.6M$-93.5M$-134.8M$-135.8M
YoY %-37.0%-40.3%-44.3%-0.7%
Margin %-479.6%-492.3%-444.0%-4787.7%-1315.4%
EV / EBIT1.7x-0.3x-3.9x-2.2x-0.6x
Net Income$-48.6M$-66.2M$-89.2M$-127.5M$-129.8M
YoY %-36.2%-34.7%-42.9%-1.8%
Net Margin-479.5%-489.3%-423.9%-4527.7%-1256.8%
EPS (GAAP)-$4.17-$2.75-$1.36-$1.14-$1.00
YoY %+34.1%+50.5%+16.2%+12.3%